Silo Wellness, Inc. is a Canada-based global psychedelics company. The Company is engaged in providing psychedelics to clients. The Company offers Jamaica psilocybin retreats at an all-inclusive seafront resort.

Employees

Sector

Pharmaceuticals

More about the company

Market Closed - Canadian Securities Exchange 15:44:08 2023-08-28 EDT			5-day change	1st Jan Change
0.0100 ^CAD	+100.00%		-.--%	-

25-08-08	Silo Wellness Inc. Appoints Richard Craven as Chief Executive Officer, Effective August 8, 2025	CI
25-08-08	Silo Wellness Inc. Appoints Richard Craven to Board of Directors, Effective August 8, 2025	CI

Market Cap	1.14M 997K 941K 858K 1.61M 109M 1.62M 11.27M 4.36M 55.62M 4.26M 4.17M 179M	P/E 2021	-0.72x	P/E 2022	-0.01x
Enterprise Value	1.88M 1.65M 1.55M 1.42M 2.65M 180M 2.67M 18.6M 7.2M 91.82M 7.04M 6.89M 295M	EV / Sales 2021	44,605,572x	EV / Sales 2022	2,673,319x
Free-Float	74.73%	Yield 2021 *	-	Yield 2022	-

25-08-08	Silo Wellness Inc. Appoints Richard Craven as Chief Executive Officer, Effective August 8, 2025	CI
25-08-08	Silo Wellness Inc. Appoints Richard Craven to Board of Directors, Effective August 8, 2025	CI
23-09-29	Silo Wellness Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	CI
23-08-28	Silo Wellness Inc. announced that it expects to receive CAD 2 million in funding	CI
23-08-28	Silo Wellness Inc. enter into a letter of intent to acquire NUGL Inc. for CAD 40.2 million.	CI
23-08-03	Kaya Group Forges Partnership with Silo Wellness for Psychedelic Wellness Experiences and Retreats	CI
23-06-28	Silo Wellness Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	CI
23-04-04	Silo Wellness Inc. Auditor Raises 'Going Concern' Doubt	CI
23-04-04	Silo Wellness Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	CI
23-04-04	Silo Wellness Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	CI
23-03-27	Michael Hartman entered into a definitive stock purchase agreement to acquire SW Holdings, Inc. from Silo Wellness Inc. for CAD 0.21 million.	CI
23-02-17	Silo Wellness Inc. Announces Resignation of Gerard Lee from as A Director of the Board	CI
22-10-20	Silo Wellness Inc. Executes Binding Term Sheet for A Joint Venture with New Frontier Ranch	CI

25-09-28	Silo Wellness Submits CSE Listing Statement for Review of Born Defense Proposed Change of Business	NE
25-08-08	Silo Wellness Appoints Defense Finance Veteran Richard Craven as CEO to Guide Strategic Transition to Born Defense	NE
25-06-02	Silo Wellness to Relist as Born Defense, a National Security Investment Issuer Focused on Ending Forever Wars and Upholding the Just War Doctrine	NE
24-03-06	Canadian Investment Regulatory Organization Trading Halt - SILO	AQ
24-02-27	Silo Wellness Announces Extension of Kaya/NUGL LOI; Annual Filings Delay	NE

Silo Wellness Inc. Stock

Stocks

SILO

CA8271242072

Pharmaceuticals

Valuation: Silo Wellness Inc.

Latest news: Silo Wellness Inc.

Press Releases: Silo Wellness Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Silo Wellness Inc.

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Manager	Title	Age	Since
Mike Arnold CEO	Chief Executive Officer	-	2022-06-08
Richard Craven CEO	Chief Executive Officer	-	2025-08-07
Winfield Ding DFI	Director of Finance/CFO	57	-

Director	Title	Age	Since
Mike Arnold CHM	Chairman	-	2017-02-07
Richard Craven BRD	Director/Board Member	-	2025-08-07

Date	Insider	Type	Main position	Quantity	% Market Cap.
8/29/25	Simon Bababeygy	Other	Director	0	0%
8/17/23	Michael Hartman	Buy	Director	908,000	0.6332%
8/17/23	Michael Hartman	Buy	Director	1,585,995	1.1060%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SILO WELLNESS INC.	+100.00%	-.--%	-.--%	-.--%	1.09M
ELI LILLY AND COMPANY	+0.13%	+2.65%	+65.61%	+114.28%	1,055B
JOHNSON & JOHNSON	+0.20%	+0.46%	+52.60%	+69.24%	654B
ABBVIE INC.	-0.29%	+0.14%	+20.96%	+70.93%	467B
ROCHE HOLDING AG	-0.85%	+0.98%	+41.29%	+44.38%	348B
NOVARTIS AG	+0.71%	+4.08%	+22.24%	+29.51%	275B
ASTRAZENECA PLC	+1.23%	+0.42%	+14.57%	+12.13%	258B
AMGEN INC.	+2.11%	+7.51%	+52.89%	+55.37%	224B
GILEAD SCIENCES, INC.	+0.83%	+0.55%	+35.99%	+101.70%	187B
NOVO NORDISK A/S	0.00%	-10.14%	-29.94%	-60.30%	171B
Average	+10.32%	+0.67%	+27.62%	+43.72%	363.84B
Weighted average by Cap.	+0.02%	+1.32%	+41.54%	+67.83%

	2021	2022
Net sales	0.12 0.11 0.1 0.09 0.17 11.51 0.17 1.19 0.46 5.88 0.45 0.44 18.9	0.34 0.29 0.28 0.25 0.47 32.19 0.48 3.33 1.29 16.44 1.26 1.23 52.85
Net income	-6.21M -5.45M -5.15M -4.69M -8.78M -595M -8.84M -61.58M -23.85M -304M -23.31M -22.81M -977M	-5.81M -5.1M -4.82M -4.39M -8.22M -557M -8.28M -57.64M -22.33M -285M -21.82M -21.35M -915M
Net Debt	175K 153K 145K 132K 247K 16.76M 249K 1.73M 672K 8.56M 657K 643K 27.53M	739K 649K 613K 558K 1.05M 70.86M 1.05M 7.33M 2.84M 36.2M 2.78M 2.72M 116M

3 years	0.01	0.01
5 years	0	2
10 years	0	7.6